Clinical Trial Update: Pharmacodynamics of Mitiglinide/Sitagliptin Compared to Mitiglinide and Sitagliptin [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamics study comparing a fixed-dose combination of mitiglinide and sitagliptin with mitiglinide alone and sitagliptin alone in Type 2 diabetes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Mitiglinide (mitiglinide)
• Mitiglinide/Sitagliptin
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED